{"id":224093,"date":"2017-06-29T00:50:33","date_gmt":"2017-06-29T04:50:33","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/mayo-connected-regenerative-medicine-startup-inks-downtown-rochester-lease-twin-cities-business-magazine.php"},"modified":"2017-06-29T00:50:33","modified_gmt":"2017-06-29T04:50:33","slug":"mayo-connected-regenerative-medicine-startup-inks-downtown-rochester-lease-twin-cities-business-magazine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/mayo-connected-regenerative-medicine-startup-inks-downtown-rochester-lease-twin-cities-business-magazine.php","title":{"rendered":"Mayo-Connected Regenerative Medicine Startup Inks Downtown Rochester Lease &#8211; Twin Cities Business Magazine"},"content":{"rendered":"<p><p>A regenerative medicine startup led by a Mayo Clinic cardiologist  is setting up shop in a downtown Rochesters Minnesota  BioBusiness Center, according to newly filed city documents.    The filing indicated Rion LLC, a Minnesota company registered to    Dr. Atta Behfar of the   Mayo Clinic Center for Regenerative Medicine, has signed a  three-year lease for just over 2,000 square feet at the  city-owned BioBusiness Center. The lease begins July 1.    The nine-story BioBusiness Center opened in downtown Rochester in  2007 as a center for innovation in biotechnology, promoting the  linkages between the researchers and practitioners at Mayo  Clinic; instructors and students at the University of Minnesota  Rochester, and the biotechnology business community. It houses  the Mayo Clinic Business Accelerator among other tenants.    Behfar is an assistant medical professor and leads a laboratory  at Mayo concentrating on applying regenerative medicine  the  practice of using stem cells to regenerate damaged or missing  tissue  to prevent and cure chronic heart conditions.  Specifically, his group focuses on development and use of both  stem cells and protein-based therapies to reverse injury caused  by lack of blood flow to the heart.    The business direction of Rion, meanwhile, appears to be  specifically geared toward a cutting-edge development in the  field of regenerative medicine  the use of extracellular  vesicles (EVs) in speeding and directing the growth of  regenerating tissues in the heart and elsewhere in the body.    EVs, long brushed off by researchers as mere debris in the  bloodstream, are membrane-enclosed spheres that break off from  the surfaces of nearly all living cells when disturbed. They  transport lipids, proteins and nucleic acids, and have now been  found to be important players in cell-to-cell communication,  influencing the behavior and even the identity of cells.    Their emerging role in regenerative medicine could potentially be  huge. For instance, by bioengineering them to transport protein  payloads from stem cells, they can be used to signal the bodys  own cells to regenerate tissue instead of transplanting the stem  cells themselves, thus eliminating the chance of host immune  system rejection.    A patent application filed last year by Rion, Behfar, Mayo Center  for Regenerative Medicine Director   Dr. Andre Terzic and two other local inventors is aimed at  adapting the healing properties of a specific type of EV into a  unique kind of product that could have wide applications. It  focuses on EVs derived from blood platelets, which are well known  to stop bleeding, promote the growth of new tissues and blood  vessels, relieve inflammation and provide a host of other  benefits.    The patent describes a system of encapsulating platelet EVs  derived from human or animal blood into a platelet honey and  delivering it to target areas of the body, such as damaged  tissues or organs. Its purported effect is to regenerate, repair  and restore damaged tissue, with possible uses including  treating heart disease; healing damaged bones or joints; wound  treatment; and cosmetic skin applications.    A brief business description provided by Rion to Rochester city  officials stated the company is focused on the delivery of  cutting edge regenerative technologies to patients at low cost  and in off-the-shelf fashion. Building on initial research at  Mayo Clinic, Rion LLC aims to develop and bring to practice  products in the space of wound healing, orthopedics and cardiac  disease.    The statement also added the company is an enthusiastic backer of  Rochesters efforts to develop a local biotech business cluster,  and is seeking to participate in the realization of the  Destination Medical Center initiative.<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/tcbmag.com\/news\/articles\/2017\/june\/mayo-connected-regenerative-medicine-startup-inks\" title=\"Mayo-Connected Regenerative Medicine Startup Inks Downtown Rochester Lease - Twin Cities Business Magazine\">Mayo-Connected Regenerative Medicine Startup Inks Downtown Rochester Lease - Twin Cities Business Magazine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A regenerative medicine startup led by a Mayo Clinic cardiologist is setting up shop in a downtown Rochesters Minnesota BioBusiness Center, according to newly filed city documents. The filing indicated Rion LLC, a Minnesota company registered to Dr <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/mayo-connected-regenerative-medicine-startup-inks-downtown-rochester-lease-twin-cities-business-magazine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-224093","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/224093"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=224093"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/224093\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=224093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=224093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=224093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}